Protagenic Therapeutics
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
149 5th Ave Rm 500, New York, New York, ...Phone Number
(212) 994-8200Website
www.protagenic.comRevenue
-Stock Symbol
PTIXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Protagenic Therapeutics
Protagenic Therapeutics is a biotechnology company focused on developing peptide-based medicines for stress-related and central nervous system disorders. The company researches brain-active compounds that regulate the bodys stress response and aims to create innovative therapies for mental health conditions such as anxiety and depression.Explore more
Protagenic Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Protagenic Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Protagenic Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Protagenic Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Protagenic Therapeutics
Funding: Get notified immidiatlly once Protagenic Therapeutics has new funding data
Check if Protagenic Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Protagenic Therapeutics is spiking on competitors!
Click to see if Protagenic Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Protagenic Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Protagenic Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Protagenic Therapeutics
Compare insights from companies similar to Protagenic Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Protagenic Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Protagenic Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Protagenic Therapeutics.
Protagenic Therapeutics financials insights
Gather financial insights about Protagenic Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
2024
Series A
$65M
Protagenic Therapeutics Tech Stack
A closer look at the technologies used by Protagenic Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Person-Based
Protagenic Therapeutics News & Media
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug CandidatesBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)
BALA CYNWYD, Pa., May 27, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.Protagenic Merges With Phytanix to Develop New Obesity Drug Among 6-Asset Pipeline
New biotech powerhouse emerges with 6 drug candidates, including potential GLP-1 competitor for obesity treatment. See full pipeline details and merger specifics.BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)
BALA CYNWYD, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Protagenic Therapeutics
Sign Up For FreeTo access detailed company insights
Protagenic Therapeutics is a biotechnology company focused on developing peptide-based medicines for stress-related and central nervous system disorders. The company researches brain-active compounds that regulate the bodys stress response and aims to create innovative therapies for mental health conditions such as anxiety and depression.... Read More
